We obtained history on previous cardiac comorbidity in each of the groups examined (Table 1), but found no relationship with the raised DSG2 autoantibody levels observed in the severe COVID-19 patients in both the acute and convalescent setting. The gene discussed is DSG2; the disease is COVID-19.